4 completed, 2 terminated, 1 recruiting. 3 Phase 4, 2 Phase 2, 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 2 | 2 | Completed 2 |
| Early Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Sulfadiazine: new trials by email Literature Review of Sulfadiazine trials Research Report on Sulfadiazine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Patients Response to Early Switch To Oral:Osteomyelitis Study oral antibiotics, intravenous antibiotics - Osteomyelitis | Early Phase 1 | Terminated | Julio Ramirez | 11 | 2014-03-06 | 2021-04-06 |
| RICE: Remission by Intra-articular Injection Plus CErtolizumab Certolizumab Pegol - Rheumatoid Arthritis | Phase 2 | Completed | Rüdiger B. Müller | 43 | 2013-11-01 | 2018-08-03 |
| Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy Pyrimethamine/Sulfadiazine, Spiramycine - Congenital Toxoplasmosis | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 149 | 2010-11-01 | 2016-09-29 |
| Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis Sulfasalazine - Arthritis, Juvenile Rheumatoid | Phase 4 | Terminated | Pfizer | 2 | 2010-06-01 | 2017-02-23 |
| Treatment of Cerebral Toxoplasmosis in HIV/AIDS TMX-SMX (Bactrim(R)), Pyrimethamine plus Sulfadiazine plus leucoverin - Toxoplasmic Encephalitis, AIDS | Phase 4 | Completed | Department of Medical Services Ministry of Public Health of Thailand | 30 | 2003-05-01 | 2007-07-31 |
| Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis Leucovorin calcium, Pyrimethamine, Spiramycin - Toxoplasmosis | Phase 4 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 600 | 2000-07-01 | 2009-05-14 |
| Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis Sulfadiazine, Clarithromycin, Atovaquone - Toxoplasmosis, Cerebral, HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 100 | 2021-10-28 |
Acquired Immunodeficiency Syndrome (2) · Arthritis, Juvenile (1) · Arthritis, Rheumatoid (1) · Communicable Diseases (1) · Encephalitis (1) · HIV Infections (1) · Immune System Diseases (1) · Osteomyelitis (1) · Rare Diseases (1) · Toxoplasmosis (1) · Toxoplasmosis, Cerebral (1) · Toxoplasmosis, Congenital (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · Assistance Publique - Hôpitaux de Paris (1) · Department of Medical Services Ministry of Public Health of Thailand (1) · Julio Ramirez (1) · Pfizer (1) · Rüdiger B. Müller (1)
United States (4) · France (1) · Mexico (1) · Switzerland (1) · Thailand (1)
Chirgwin K (1) · David Seligson, MD (1) · Julio Ramirez, MD (1) · Laurent Mandelbrot, MD (1) · Luft B (1) · Rima McLeod (1) · Rueediger B Mueller, MD (1) · Subsai Kongsaengdao, M.D. (1)
PMID 15276398, PMID 15840453, PMID 17517949, PMID 19588358, PMID 22499837, PMID 22530208, PMID 4902833, PMID 8948280